Expert Opinion on Therapeutic Targets

Anti-infectives Targeting the isoprenoid pathway of Toxoplasma gondii
pp. 253-263(11)
Authors: Moreno, Silvia NJ; Li, Zhu-Hong

Nuclear factor kappa B and hepatitis viruses
pp. 265-280(16)
Authors: Guan, Yong-Song; He, Qing; Wang, Ming-Quan; Li, Ping

Intracellular immune dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: state of the art and therapeutic implications
pp. 281-289(9)
Authors: Nijs, Jo; Frémont, Marc

Cysteine cathepsin S as an immunomodulatory target: present and future trends
pp. 291-299(9)
Authors: Gupta, Suman; Singh, Rakesh Kumar; Dastidar, Sunanda; Ray, Abhijit

Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease
pp. 301-312(12)
Authors: Mitsuyama, Keiichi; Sata, Michio

CD4⁺CD25⁺ regulatory T cells: a therapeutic target for liver diseases
pp. 313-326(14)
Authors: Zheng, Ming-Hua; Gu, Dian-Na; Braddock, Martin; Leishman, Andrew J; Jin, Chang; Wen, Jin-Sheng; Gong, Yue-Wen; Chen, Yong-Ping

Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?
pp. 327-339(13)
Authors: Giachini, Fernanda RC; Callera, Glaucia E; Carneiro, Fernando S; Tostes, Rita C; Webb, R Clinton

CD70 as a therapeutic target in human malignancies
pp. 341-351(11)
Author: Grewal, Iqbal S

Targeting signaling pathways in ovarian cancer
pp. 353-365(13)
Authors: Reibenwein, J; Krainer, M

Protein kinase G as a therapeutic target for the treatment of metastatic colorectal cancer
pp. 367-376(10)
Author: Browning, Darren D

6th International Symposium on Aldosterone and ENaC: from gene to disease
pp. 377-382(6)
Authors: Fuller, Peter J; Young, Morag J